FDA Updates EUA to Allow Pfizer Boosters in 16- and 17-Year Olds

The FDA has revised Pfizer/BioNTech’s Emergency Use Authorization (EUA), allowing a booster of the companies’ COVID-19 vaccine in teenagers aged 16 and 17 six months following completion of a primary vaccination series.
Source: Drug Industry Daily